Arm Restriction Strategies After Cardiac Device Surgery
(LENIENT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if altering arm movement restrictions after receiving a cardiac implant can enhance recovery and reduce complications. It compares strict restrictions, such as no lifting or moving the arm for several weeks, to more lenient ones, with only a few limits for a short time. The trial targets individuals who recently received a new cardiac device. Participants contribute to identifying which approach leads to a better recovery experience. As a Phase 4 trial, the treatment is already FDA-approved and proven effective, and this research seeks to understand how it benefits more patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What is the safety track record for these arm restriction strategies?
Research has shown that moving soon after receiving a heart device is usually safe and doesn't increase complications. This trial compares two different sets of guidelines for arm movement after surgery.
The lenient arm restriction allows more freedom. Patients can move their arm freely after a short period, with no limits on reaching overhead or lifting weights, except for activities like shoveling or playing sports for a few days.
The strict arm restriction is more cautious. Patients should avoid lifting their arm above their head and lifting heavy objects for eight weeks. They should also refrain from sports or activities like swimming or golf during this time.
Both sets of guidelines are considered safe and align with common practices in Canada. No evidence suggests that either set causes harm. Therefore, participants in either group are expected to tolerate the guidelines well.12345Why are researchers excited about this trial?
Researchers are excited about the trial comparing lenient and strict arm restrictions after cardiac device surgery because it may offer insights into patient recovery and quality of life. Currently, strict movement limitations are standard to prevent complications, but they can be cumbersome and affect daily activities. The lenient approach, which allows more freedom in arm movement sooner, could potentially lead to a quicker return to normal activities without increasing risks. This trial aims to determine if easing restrictions can maintain safety while improving comfort and convenience for patients.
What evidence suggests that this trial's arm restriction strategies could be effective for improving patient experience and reducing complications after cardiac device surgery?
This trial will compare two post-operative arm restriction strategies after cardiac device surgery. Research has shown that allowing more arm movement might improve recovery without increasing complications. Participants in the lenient arm restriction group will follow relaxed guidelines, which studies suggest are as safe as stricter rules, with no difference in complication rates. This approach can enhance daily life by permitting more normal activities. In contrast, the strict arm restriction group will adhere to traditional rules designed to prevent issues like surgical wound reopening. However, strong evidence does not support that strict rules are more effective at preventing these issues than relaxed ones. Overall, the trial aims to determine if relaxed rules offer a good balance between safety and comfort for patients.23678
Who Is on the Research Team?
David Birnie
Principal Investigator
Ottawa Heart Institute Research Corporation
Are You a Good Fit for This Trial?
This trial is for patients who have just had surgery to receive a Cardiac Implantable Electronic Device (CIED) and are facing postoperative recovery. It's open to those getting at least one new endovascular lead but not for patients only having their CIED generator replaced.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either lenient or strict arm restriction instructions post CIED surgery
Crossover
Arm restriction instructions are changed every 7 months as per the crossover design
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of primary and secondary outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Lenient Arm Restriction
- Strict Arm Restriction
Lenient Arm Restriction is already approved in Canada for the following indications:
- Post-operative care for patients receiving Cardiac Implantable Electronic Devices (CIEDs)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Heart Institute Research Corporation
Lead Sponsor